ARS Pharmaceuticals, Inc. (SPRY) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.74 | -2275.0% |
| 2024 | $0.08 | +114.0% |
| 2023 | $-0.57 | +34.5% |
| 2022 | $-0.87 | -24.3% |
| 2021 | $-0.70 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.74 | -2275.0% |
| 2024 | $0.08 | +114.0% |
| 2023 | $-0.57 | +34.5% |
| 2022 | $-0.87 | -24.3% |
| 2021 | $-0.70 | — |